12
Views
7
CrossRef citations to date
0
Altmetric
Articles

Responses of Mastomys coucha, that have been infected with Brugia malayi and treated with diethylcarbamazine or albendazole, to re-exposure to infection

, , , &
Pages 817-830 | Published online: 18 Jul 2013

References

  • Bhattacharya, S., Singh, U., Murthy, P. K. & Katiyar, J. C. (1997). Immunogenicity of purified proteins of Brugia malayi. In Proceedings of Second Symposium on Vectors and Vector Borne Diseases, pp. 149-154. Bhubaneswar, India: National Academy of Vector Borne Diseases.
  • Bosshardt, S. C., Coleman, S. U., McVay, C. S., Jones, K. L. & Klei, T. R. (1995). Impact of microfilaraemia on maintenance of hyporesponsive cellular immune response in Brugia infected gerbils (Meriones unguiculatus). Infection and Immunity, 63,940–945.
  • Chatterjee, R. K., Singh, D. P. & Mishra, S. (1992). Acanthocheilonema vitae in Mastomys natalensis: evaluation of efficacy of microfilarial vaccine. Current Science, 63,98–102.
  • Dacie, J. V. & Lewis, S. M. (1995). Practical Haemat-ology, 8th Edn. London: Churchill Livingstone.
  • Dube, A., Srivastava, J. K., Sharma, P., Chaturvedi, A., Katiyar, J. C. & Naik, S. (1999). Leishmania donovani: cellular and humoral immune responses in Indian langur monkeys, Presbytis entellus. Acta Tropica, 73, 37–48.
  • Fatma, N., Murthy, P. K. & Chatterjee, R. K. (1994). Chemotherapeutic response of filarial parasites to ivermectin. In Tropical Diseases Molecular Biology and Control Strategies, eds Kumar, S., Sen, A. K., Dutta, G. P. & Sharma, R. N. pp. 55-64. New Delhi, India: Publications and Information Directorate, Council of Scientific and Industrial Research.
  • Ghosh, R. P., Murthy, P. K., Tyagi, K., Murthy, P. S. R. & Chatterjee. R. K. (1999). Longitudinal cellular immune responses in asymptomatic and symptomatic Brugia malayi-infected leaf monkey Presbytis entellus. Journal of Parasitology, 85, 861–866.
  • Gleich, G. J. (1989). Eosinophils, basophils, and mast cells. Journal of Allergy and Clinical Immunology, 84, 1024–1027.
  • Greene, B. M., Taylor, H. R., Cupp, E. W., Murphy, R. P., White, A. T., Aziz, M. A., Schulz-Key, H., d'Anna, S. A., Newland, H. S. & Goldschmidt, L. P. (1985). Comparison of ivermectin and diethylcar-bamazine in the treatment of onchocerciasis. New England Journal of Medicine, 313, 133-138.
  • Harbrink, M., Terhell, A. J., Abadi, G. K., Mitsui, Y. & Yazdanbakhsh. M. (1999). Inflammatory cytokines following diethylcarbamazine (DEC) treatment of different clinical groups of lymphatic filariasis. Trans-actions of Royal Society of Tropical Medicine and Hygiene, 93, 665–672.
  • Katiyar, J. C., Misra, A., Gupta, S., Visen, P. K. S., Murthy, P. K. & Sen, A. B. (1987). Efficacy of a sub-stituted methyl benzimidazole carbamate against developing and adult helminth parasites. Veterinary Parasitology, 23,193–204.
  • King, C. L. (2001). Transmission intensity and human immune responses to lymphatic filariasis. Parasite Immunology, 23,363–371.
  • King, C. L., Kumaraswami, V., Poindexter, R. W., Kumari, S., Jayaraman D, Ailing, D. W., Ottesen, E. A. & Nutman, T. B. (1992). Immunological tolerance in lymphatic filariasis. Diminished parasite specific T and B-lymphocytes precursor frequency in the microfilaraemic state. Journal of Clinical Investigation, 89, 1403–1410.
  • Klei, T. R., McVay, C. S., Dennis, V. A., Coleman, S. V., Enright, F. M. & Casy, H. W. (1990). Brugia pahangi: effects of infection, duration and parasite burden on lymphatic lesion severity, granulomatous hypersensitivity and immune responses in jirds (Meriones unguiculatus). Experimental Parasitology, 71, 393–405.
  • Kurniawan, A., Yazdanbakhsh, M., van Ree, R., Aalberse, R., Selkirk, M. E., Parton°, F. & Maizels, R. M. (1993). Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis. Journal of Immunology, 150, 3941–3950.
  • Lammie, P. J., Hightower, A. W., Richards Jr, F. O., Bryan, R. T., Spencer, H. C., McNeeley, D. F., McNeeley, M. B. & Eberhard, M. L.(1992). Alterations in filarial antigen specific immunologic reactivity following treatment with ivermectin and diethylcarbamazine. American Journal of Tropical Medicine and Hygiene, 46, 292–295.
  • Lammie, P. J., Reiss, M. D., Dimock, K. A., Streit, T. G., Roberts, J. M. & Eberhard, M. L. (1998). Longi-tudinal analysis of the development of filarial infection and antifilarial immunity in a cohort of Haitian children. American Journal of Tropical Medicine and Hygiene, 59, 217–221.
  • Lawrence, R. A. & Devaney, E. (2001). Lymphatic filariasis: parallels between the immunology of infec-tion in humans and mice. Parasite Immunology, 23, 353–361.
  • Lowry, O. H., Rosebrough, N. R., Fan, A. L. & Randall. R. J. (1951). Protein measurement with Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
  • Murthy, P. K., Tyagi, K., Roy Chowdhury, T. K. & Sen, A. B. (1983). Susceptibility of Mastomys natalensis (GRA strain) to a subperiodic strain of human Brugia malayi. Indian Journal of Medical Research, 77,623–630.
  • Murthy, P. K., Haq, W., Tyagi, K., Mathur, K. B. & Chatterjee, R. K. (1992). Brugia malayi in Mastomys natalensis: effect of immunostimulators on establish-ment and course of infection. Tropical Medicine, 34, 63–69.
  • Murthy, P. K., Agarwal, A., Katiyar, J. C. & Sahib, M. K. (1995). Immune response patterns in different stages of active Brugia malayi infection in Mastomys coucha. Journal of Parasitic Disease, 19, 135–140.
  • Murthy, P. K., Murthy, P. S. R, Tyagi, K. & Chatterjee, R. K. (1997). Fate of implanted infective larvae of Brugia malayi in the peritoneal cavity of Mastomys natalensis and Meriones unguiculatus. Folia Parasitologica, 44,302–304.
  • Murthy, P. K., Dennis, V. A., Lasater, B. L. & Philipp, M. T. (2000). Interleukin-10 modulates pro-inflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins. Infection and Immunity, 68, 6663–6669.
  • Murthy, P. K., Srivastava, K. & Murthy, P. S. R. (2004). Responses of Brugia malayi-Presbytis entellus, a non-human primate model of filariasis, to DEC, ivermectin and CDRI compound 82-437. Current Science, 86, 101–108.
  • Oliveira, S. H., Fonseca, S. G., Romào, P. R., Figueiredo, F., Ferreira, S. H. & Cunha, F. Q. (1998). Microbicidal activity of eosinophils is associ-ated with activation of the arginine-NO pathway. Parasite Immunology, 20, 405–412.
  • Ottesen, E. A. (1985). Efficacy of diethylcarbamazine in eradicating with lymphatic-dwelling filariae in humans. Review of Infectious Diseases, 7,341–356.
  • Ottesen, E. A., Weller, P. F. & Heck, L. (1977). Specific cellular immune unresponsiveness in human filariasis. Immunology, 33,413–421.
  • Ottesen, E. A., Duke. B. O. L., Karam, M. & Behbehani, K. (1997). Strategies and tools for the control/elimination of lymphatic filariasis. Bulletin of the World Health Organization, 75,491–503.
  • Ottesen, E. A., Ismail, M. M. & Horton, J. (1999). The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitology Today, 15, 382-386.
  • Piessens, W. F., Ratiwayanto, S., Tuti, S., Palmieri, J. H., Piessens, P. W., Koiman, I. & Dennis, D. T. (1980). Antigen specific suppressor cells and suppres-sor factors in human filariasis with Brugia malayi. New England Journal of Medicine, 302, 833-837.
  • Piessens, W. F., Ratiwayanto, S., Piessens, P. W., Tuti, S., McGreevy, P. P., Darwis, F., Palmieri, J. R., Koiman, I. & Dennis, D. T. (1981). Effect of treat-ment with diethylcarbamazine on immune responses to filarial antigens in patients infected with Brugia malayi. Acta Tropica, 38,227–234.
  • Piessens, W. F., Parton°, F., Hoffman, S. L., Ratiwayanto, S., Piessens, P. W., Palmieri, J. R., Koiman, I. & Dennis, D. T. (1982). Antigenic specific suppressor T lymphocytes in human lym-phatic filariasis. New England Journal of Medicine, 307, 144–148.
  • Ramirez, T., Benitez-Bribiesca, L., Ostrosky-Wegman, P. & Herrera, L. A. (2001). In vitro effects of albendazole and its metabolites on the cell prolifera-tion kinetics and micronuclei frequency of stimulated human lymphocytes. Archives of Medical Research, 32, 119–122.
  • Roberts, M., Butterworth, A. E., Kimani, G., Kamau, T., Fulford, A. J., Dunne, D. W., Ouma, J. H. & Sturrock, R. F. (1993). Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infection and Immunity, 61, 4984–4993.
  • Schares, G. & Zahner, H. (1994). IgG subclasses of the multimammate rat, Mastomys coucha: isolation and characterization of IgG1 and IgG2. Journal of Experimental Animal Science, 36,55–69.
  • Sim, K. L., Kwa, B. H. & Mak, J. W. (1982). Immune responses in human Brugia malayi infections; serum dependent cell-mediated destruction of infective larvae in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 76,362–370.
  • Spencer, L., Shultz, L. & Rajan, T. V. (2003). T cells are required for host protection against Brugia malayi but need not produce or respond to interleukin-4. Infection and Immunity, 71,3097–3106.
  • Spry, J. F. & Kumaraswami, V. (1982). Tropical eosinophilia. Seminars in Hematology, 19, 107–115.
  • Tandon, A., Murthy, P. K., Saxena, R. P., Sen, A. B. & Saxena, K. C. (1988). Dot-ELISA for diagnosis of lymphatic filariasis. Indian Journal of Medical Research, 87, 429–433.
  • Turner, R. F., Rockett, K. A., Ottesen, E. A., Francis, H., Awadzi, K. & Clark, I. A. (1994). Interleukin-6 and tumor necrosis factor in the pathogenesis of adverse reactions after treatment of lymphatic filari-asis and onchocerciasis. Journal of Infectious Diseases, 169, 1071–1075.
  • Tyagi, K., Murthy, P. K., Chatterjee, R. K. & Sen, A. B. (1986a). Chemotherapeutic response of Brugia malayi to antifilarials in Mastomys natalensis. Indian Journal Parasitology, 10, 195–207.
  • Tyagi, K., Murthy, P. K. & Sen, A. B. (1986b). Effect of some known antifilarials on the immune responses of Mastomys natalensis infected with Brugia malayi. Indian Journal Medical Research, 83, 155–161.
  • Voller, A. & Bidwell, D. E. (1976). Enzyme immunoas-say for parasitic diseases. Transactions of the Royal Society of Tropical Medicine and Hygiene, 70,98–106.
  • Yazdanbakhsh, M., Paxton, W. A., Kruize, Y. C., Sartono, E., Kurniawan, A., van het Wout, A., Selkirk, M. E., Parton°, F. & Maizels, R. M. (1993). T cell responsiveness correlates differentially with antibody isotype levels in clinical and asymptomatic filariasis. Journal of Infectious Diseases, 167, 925-931. Zahner, H. & Schares, G. (1993). Experimental chemo-therapy of filariasis: comparative evaluation of the efficacy of filaricidal compounds in Mastomys coucha infected with Litomosoides carinii, Acanthocheilonema viteae, Brugia malayi and B. pahangi. Acta Tropica, 52, 221–266.
  • Zheng, H., Piessens, W. F., Tao, Z., Cheng, W., Wang, S., Cheng, S., Ye, Y., Luo, L., Chen, X. & Gan, G. (1991). Efficacy of ivermectin for control of microfila-remia recurring after treatment with diethylcarbam-azine. I. American Journal of Tropical Medicine and Hygiene, 45, 168–174.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.